COCRYSTAL PHARMA, INC.

Profile

Company Names

COCRYSTAL PHARMA, INC.
BIOZONE PHARMACEUTICALS, INC.

Addresses

1860 MONTREAL ROAD, TUCKER, GA 30084

19805 N CREEK PKWY, BOTHELL, WA 98011

550 SYLVAN AVENUE, SUITE 101, ENGLEWOOD CLIFFS, NJ 07632

Phone Numbers

678-892-8800
(425) 398-7178
(201) 608-5101

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$28,917,571.00

Number of Funding Rounds:

17
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
17
2017-04-25 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
16
2016-09-01 
$4,008,201.00 
$4,008,201.00 
$0.00 
Equity 
15
2016-03-15 
$5,004,370.00 
$5,004,370.00 
$0.00 
Equity 
14
2014-01-16 
$2,750,000.00 
$2,750,000.00 
$0.00 
Equity 
13
2014-01-02 
$0.00 
$0.00 
$0.00 
Equity 
12
2013-10-22 
$3,500,000.00 
$3,500,000.00 
$0.00 
Equity 
11
2013-08-26 
$2,000,000.00 
$2,000,000.00 
$0.00 
 
10
2013-04-12 
$800,000.00 
INDEFINITE 
INDEFINITE 
Equity 
9
2012-06-13 
$200,000.00 
$200,000.00 
$0.00 
Debt 
8
2012-04-18 
$250,000.00 
$250,000.00 
$0.00 
 
7
2012-03-13 
$1,000,000.00 
$1,000,000.00 
$0.00 
 
6
2012-02-24 
$2,300,000.00 
$2,300,000.00 
$0.00 
 
5
2012-01-11 
$650,000.00 
$650,000.00 
$0.00 
 
4
2011-11-30 
$250,000.00 
$250,000.00 
$0.00 
Equity 
3
2011-10-31 
$455,000.00 
$455,000.00 
$0.00 
Equity 
2
2011-09-22 
$500,000.00 
$500,000.00 
$0.00 
 
1
2011-03-29 
$2,250,000.00 
$2,250,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
S 
BLOCK 
DIRECTOR
COCRYSTAL PHARMA, INC.
DAVID 
S. 
BLOCK 
DIRECTOR
GLIKNIK INC   |  COCRYSTAL PHARMA, INC.
CURTIS 
 
DALE 
EXECUTIVE OFFICER
COCRYSTAL PHARMA, INC.
CURTIS 
A 
DALE 
EXECUTIVE OFFICER
COCRYSTAL PHARMA, INC.
DANIEL 
 
FISHER 
EXECUTIVE OFFICER, DIRECTOR
BIOZONE PHARMACEUTICALS, INC.   |  AMARILLO BIOSCIENCES INC   |  GOOD LIBATIONS LLC   |  NMB THERAPEUTICS, INC
PHILLIP 
 
FROST 
DIRECTOR
OPKO HEALTH, INC.   |  PROLOR BIOTECH, INC.   |  CASTLE BRANDS INC   |  COCRYSTAL DISCOVERY INC   |  LADENBURG THALMANN FINANCIAL SERVICES INC   |  MORGAN SOLAR INC.   |  ZEBRA BIOLOGICS, INC.   |  BIOZONE PHARMACEUTICALS, INC.   |  SEVION THERAPEUTICS, INC.   |  COCRYSTAL PHARMA, INC.
PHILLIP 
A 
FROST 
DIRECTOR
COCRYSTAL PHARMA, INC.
JANE 
 
HSIAO 
DIRECTOR
NEOVASC INC   |  COCRYSTAL DISCOVERY INC   |  TISSUETECH, INC.   |  BIOZONE PHARMACEUTICALS, INC.
JANE 
H 
HSIAO 
DIRECTOR
COCRYSTAL PHARMA, INC.   |  TRANSENTERIX INC.
JANE 
H. 
HSIAO 
DIRECTOR
OPKO HEALTH, INC.   |  PROLOR BIOTECH, INC.   |  SAFESTITCH MEDICAL, INC.   |  NON INVASIVE MONITORING SYSTEMS INC /FL/   |  COCRYSTAL PHARMA, INC.
BRIAN 
 
KELLER 
EXECUTIVE OFFICER, DIRECTOR
BIOZONE PHARMACEUTICALS, INC.   |  PRIME INCOME PROPERTIES-ASPEN TERRACE, LLC
ROGER 
 
KORNBERG 
DIRECTOR
COCRYSTAL DISCOVERY INC   |  BIOZONE PHARMACEUTICALS, INC.   |  SENSOR-KINESIS CORP   |  COGNOS THERAPEUTICS INC   |  XENETIC BIOSCIENCES, INC.   |  AUTONOMOUS MEDICAL DEVICES INC   |  NEOTX HOLDINGS LTD.
SAM 
 
LEE 
EXECUTIVE OFFICER, DIRECTOR
COCRYSTAL DISCOVERY INC   |  INTEGRATED PHOTOVOLTAICS, INC.   |  C2 DESIGN AUTOMATION   |  BIOZONE PHARMACEUTICALS, INC.   |  COCRYSTAL PHARMA, INC.   |  PHYSICIANS INTEGRATED NETWORK, LLC   |  CIVIK BIOTECH INC
SAM 
A 
LEE 
EXECUTIVE OFFICER
COCRYSTAL PHARMA, INC.
WALT 
ADDISON 
LINSCOTT 
EXECUTIVE OFFICER
COCRYSTAL PHARMA, INC.
JAMES 
 
MARTIN 
EXECUTIVE OFFICER
DESIGNLINE INTERNATIONAL CORP   |  JASPER VENTURES INC.   |  INTERNATIONAL MONEY MANAGEMENT, INC.   |  ST. JOHN CV CO-MANAGEMENT COMPANY, LLC   |  FRESENIUS VASCULAR CARE MEMPHIS MSO, LLC   |  VAPOR CORP.   |  VBI VACCINES INC/BC   |  MOTUS GI HOLDINGS, INC.   |  MOTUS GI MEDICAL TECHNOLOGIES, LTD.   |  COCRYSTAL PHARMA, INC.   |  ERIE DOWNTOWN EQUITY FUND, LLC   |  RALLYCORP, INC.   |  NORDWAND SPECIAL OPPORTUNITIES II LLC   |  NORDWAND EARLY OPPORTUNITIES I LLC   |  NORDWAND HEALTHCARE OPPORTUNITIES I LLC   |  NORDWAND SPECIAL OPPORTUNITIES III LLC
DOUGLAS 
L 
MAYERS 
EXECUTIVE OFFICER
COCRYSTAL PHARMA, INC.
ELLIOT 
M 
MAZA 
EXECUTIVE OFFICER, DIRECTOR
BIOZONE PHARMACEUTICALS, INC.
ELLIOT 
M. 
MAZA 
EXECUTIVE OFFICER, DIRECTOR
BIOZONE PHARMACEUTICALS, INC.
GERALD 
 
MCGUIRE 
EXECUTIVE OFFICER
BIOZONE PHARMACEUTICALS, INC.
JEFFREY 
A 
MECKLER 
EXECUTIVE OFFICER, DIRECTOR
COCRYSTAL PHARMA, INC.
CHRISTIAN 
 
OERTLE 
EXECUTIVE OFFICER
BIOZONE PHARMACEUTICALS, INC.
ROBERTO 
 
PREGO-NOVO 
DIRECTOR
BIOZONE PHARMACEUTICALS, INC.
STEVEN 
 
RUBIN 
DIRECTOR
NEOVASC INC   |  CARDO MEDICAL, INC.   |  BIOZONE PHARMACEUTICALS, INC.   |  SEVION THERAPEUTICS, INC.   |  ONSOURCE, LLC   |  IDI, INC.   |  VBI VACCINES INC/BC   |  CHROMADEX CORP.   |  HUMBITION II, LLC
STEVEN 
D 
RUBIN 
DIRECTOR
COCRYSTAL PHARMA, INC.
STEVEN 
D. 
RUBIN 
DIRECTOR
OPKO HEALTH, INC.   |  PROLOR BIOTECH, INC.   |  CASTLE BRANDS INC   |  COCRYSTAL DISCOVERY INC   |  SAFESTITCH MEDICAL, INC.   |  SEARCHMEDIA HOLDINGS LTD   |  NON INVASIVE MONITORING SYSTEMS INC /FL/   |  TIGER MEDIA, INC.   |  IDI, INC.   |  COCRYSTAL PHARMA, INC.   |  COGINT, INC.
RAYMOND 
F 
SCHINAZI 
DIRECTOR
COCRYSTAL PHARMA, INC.
RAYMOND 
F. 
SCHINAZI 
DIRECTOR
CENTROSE LLC   |  RFS PHARMA, LLC   |  COCRYSTAL PHARMA, INC.   |  GLIKNIK INC
GARY 
 
WILCOX 
EXECUTIVE OFFICER, DIRECTOR
CYTOMX THERAPEUTICS, INC.   |  BIOZONE PHARMACEUTICALS, INC.   |  CYTOMX THERAPEUTICS HOLDINGS, LLC   |  COCRYSTAL PHARMA, INC.   |  ADRX, INC.
GARY 
A 
WILCOX 
DIRECTOR
COCRYSTAL PHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-05-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-04-25 
2016-09-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-09-01 
2016-03-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-03-15 
2014-01-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2014-01-16 
2014-01-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2014-01-02 
2013-11-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2013-10-22 
2013-09-05
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2013-08-26 
2013-04-22
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
2012-06-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2012-06-13 
2012-05-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2012-04-18 
2012-04-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2011-03-29 
2012-04-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-11-30 
2012-04-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2011-09-22 
2012-04-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-10-31 
2012-03-20
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2012-03-13 
2012-03-09
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2012-02-24 
2012-01-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
 
2012-01-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
PALLADIUM CAPITAL ADVISORS, LLC
129400
NONE
NONE
NONE
NONE
PALLADIUM CAPITAL ADVISORS, LLC
129400
BROADBAND CAPITAL MANAGEMENT, LLC
48001
NONE
NONE